Financhill
Back

Orgenesis Quote, Financials, Valuation and Earnings

Orgenesis Price Quote

$0.54
+0.01 (+2.74%)
(Updated: May 2, 2024 at 9:50 AM ET)

Orgenesis Key Stats

Sell
37
Orgenesis (ORGS) is a Sell

Day range:
$0.50 - $0.54
52-week range:
$0.25 - $1.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
28.53
P/B ratio:
0%

Volume:
12K
Avg. volume:
291.7K
1-year change:
-50.88%
Market cap:
$18.1M
Revenue:
$530K
EPS:
$-1.96

How Much Does Orgenesis Make?

  • How Much Are Orgenesis's Sales Annually?
    ORGS Revenues are $530K
  • How Much Profit Does Orgenesis's Make A Year?
    ORGS net income is -$55.4M

Is Orgenesis Growing As A Company?

  • What Is Orgenesis's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.99%
  • What Is Orgenesis's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Orgenesis Stock Price Performance

  • Did Orgenesis Stock Go Up Last Month?
    Orgenesis share price went down by -9.52% last month
  • Did ORGS's Share Price Rise Over The Last Year?
    ORGS share price fell by -50.88% over the past 1 year

What Is Orgenesis 52-Week High & Low?

  • What Is Orgenesis’s 52-Week High Share Price?
    Orgenesis has traded as high as $1.50 over the past 52 weeks
  • What Is Orgenesis’s 52-Week Low Share Price?
    Orgenesis has traded as low as $0.25 over the past 52 weeks

Orgenesis Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Orgenesis?

  • How Much Debt Does Orgenesis Have?
    Total long term debt quarterly is $22.3M
  • How Much Cash Does Orgenesis Have?
    Cash and short term investments quarterly total is $837K
  • What Is Orgenesis’s Book Value Per Share?
    Book value per share is -0.66

Is Orgenesis Cash Flow Positive?

  • What Is ORGS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14.8M
  • What Is Orgenesis’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $13.6M
  • What Is Orgenesis’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.7M

Orgenesis Return On Invested Capital

  • Is Management Doing A Good Job?
    ORGS return on invested capital is -117.67%
  • What Is Orgenesis Return On Assets?
    ROA measures how assets are converting to revenues and is -92.64%
  • What Is ORGS Return On Equity?
    ROE is a measure of profitability and is -206.63%

Orgenesis Earnings Date & Stock Price

  • What Is Orgenesis's Stock Price Today?
    A single share of ORGS can be purchased today for 0.53
  • What Is Orgenesis’s Stock Symbol?
    Orgenesis trades on the nasdaq under the ticker symbol: ORGS
  • When Is Orgenesis’s Next Earnings Date?
    The next quarterly earnings date for Orgenesis is scheduled on May 10, 2024
  • When Is ORGS's next ex-dividend date?
    Orgenesis's next ex-dividend date is May 2, 2024
  • How To Buy Orgenesis Stock?
    You can buy Orgenesis shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Orgenesis Competitors

  • Who Are Orgenesis's Competitors?
    Below is a list of companies who compete with Orgenesis or are related in some way:
    • Altimmune Inc (ALT)
    • Actinium Pharmaceuticals Inc (ATNM)
    • Dare Bioscience Inc (DARE)
    • Oragenics Inc (OGEN)
    • Verastem Inc (VSTM)

Orgenesis Dividend Yield

Data Unavailable

Orgenesis Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -530%
Revenue: -98.79% -99.19%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 1041.55%

Major Shareholders

  • How many ORGS shares are owned by institutional investors?
    2.7M ORGS shares are owned by institutional investors
  • How many ORGS shares are owned by insiders?
    2.3M ORGS shares are owned by insiders